155 related articles for article (PubMed ID: 22512262)
21. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
[TBL] [Abstract][Full Text] [Related]
22. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.
Burroughs SK; Kaluz S; Wang D; Wang K; Van Meir EG; Wang B
Future Med Chem; 2013 Apr; 5(5):553-72. PubMed ID: 23573973
[TBL] [Abstract][Full Text] [Related]
24. HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery.
Semenza GL
Curr Pharm Des; 2009; 15(33):3839-43. PubMed ID: 19671047
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
26. Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradation.
Jones DT; Pugh CW; Wigfield S; Stevens MF; Harris AL
Clin Cancer Res; 2006 Sep; 12(18):5384-94. PubMed ID: 17000671
[TBL] [Abstract][Full Text] [Related]
27. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.
Palayoor ST; Tofilon PJ; Coleman CN
Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.
Ahmad A; Ahmad S; Malcolm KC; Miller SM; Hendry-Hofer T; Schaack JB; White CW
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):78-85. PubMed ID: 23492195
[TBL] [Abstract][Full Text] [Related]
29. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
31. Multiplicity of hypoxia-inducible transcription factors and their connection to the circadian clock in the zebrafish.
Pelster B; Egg M
Physiol Biochem Zool; 2015; 88(2):146-57. PubMed ID: 25730270
[TBL] [Abstract][Full Text] [Related]
32. HIF-2α, but not HIF-1α, mediates hypoxia-induced up-regulation of Flt-1 gene expression in placental trophoblasts.
Sasagawa T; Nagamatsu T; Morita K; Mimura N; Iriyama T; Fujii T; Shibuya M
Sci Rep; 2018 Nov; 8(1):17375. PubMed ID: 30478339
[TBL] [Abstract][Full Text] [Related]
33. The HIF pathway: implications for patterns of gene expression in cancer.
Wykoff CC; Pugh CW; Harris AL; Maxwell PH; Ratcliffe PJ
Novartis Found Symp; 2001; 240():212-25; discussion 225-31. PubMed ID: 11727931
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells.
Hu CJ; Iyer S; Sataur A; Covello KL; Chodosh LA; Simon MC
Mol Cell Biol; 2006 May; 26(9):3514-26. PubMed ID: 16611993
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the HIF-system in human macrophages--differential regulation of HIF-α subunits under sustained hypoxia.
Poitz DM; Augstein A; Hesse K; Christoph M; Ibrahim K; Braun-Dullaeus RC; Strasser RH; Schmeißer A
Mol Immunol; 2014 Feb; 57(2):226-35. PubMed ID: 24176785
[TBL] [Abstract][Full Text] [Related]
36. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
37. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.
Aquino-Gálvez A; González-Ávila G; Delgado-Tello J; Castillejos-López M; Mendoza-Milla C; Zúñiga J; Checa M; Maldonado-Martínez HA; Trinidad-López A; Cisneros J; Torres-Espíndola LM; Hernández-Jiménez C; Sommer B; Cabello-Gutiérrez C; Gutiérrez-González LH
Oncol Rep; 2016 Jan; 35(1):577-83. PubMed ID: 26548300
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
39. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
[TBL] [Abstract][Full Text] [Related]
40. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]